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Agenda 
 
DHI Board Meeting: Tuesday 30th May 2017, 10am ± 13.30pm 
Venue: Boardroom, Inovo Building, 121 George St, Glasgow, G1 1RD 
 
 
 
 
1. 
 
&KDLU¶V,QWURGXFWLRQVDQG$SRORJLHV 
 
GC 
 
2. 
 
Appointment of New Chairman and Board Endorsement 
 
GC 
 
3. 
 
New Chairman Opening Remarks 
 
JJ 
 
4. 
 
Minutes of last meeting 16/02/17 
 
JJ 
 
5. CEO Recruitment and Governance  DL 
 
6. 
 
Update on Board Papers  
 
DC 
 
7. 
 
Challenge Themes Status 
 
CC 
 
8. 
 
Finance Report ± including Funding Status 
 
HA 
 
9. 
 
Strategy with Corporates including Demonstrator 
Environment 
 
HA 
10. 
 
Marcoms Update  
 
HA 
 
11. SFC Quarter 3 MEF Report for Approval HA 
 
12. 
 
Any Other Competent Business All 
13. 
 
Date and Time of Next Meeting ± To be confirmed 
 
JJ  
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1. Minutes of the Previous Meeting 
 
DIGITAL HEALTH & CARE INSTITUTE 
BOARD MEETING 
 
Minutes: 16th February 2017 
Chairing: 
Professor George Crooks,  
Chairman, Digital Health & Care Institute 
Present: Mr Dave Clark 
Interim CEO 
Digital Health & Care Institute 
 Professor Harry Burns 
UoS 
 Mr Hugh Hall 
Chief Operating Officer  
UoS  
 
 Ian Blewett, 
Scottish Enterprise 
 Madeline Smith, 
Head of Development 
Institute of Design Innovation, 
Glasgow School of Art 
 David Littlejohn 
Executive Dean,  
UoS 
 
 Charles Sweeney, CEO, 
Critiqom 
 Donna Chisholm, 
Regional Head of Sectors, 
Innovation and Programmes, 
Highlands & Islands 
Enterprise 
 
 Mr John Connaghan 
Chief Operating Officer 
NHS Scotland 
 Louise McKean 
Solicitor and Contracts 
Manager 
UoS 
 
Conference line %ULDQ2¶&RQQRU&KDLU(XURSHDQConnected 
Health Alliance, UK 
 Irene McAra-McWilliam 
Deputy Director (Innovation) 
Glasgow School of Art 
 
 Helen Raftopoulos 
Scottish Funding Council 
  
Apologies Professor Andrew Morris 
University of Edinburgh 
  
Visiting 
attendees 
 
Stuart Deed 
Strategic Funding Director 
Digital Health & Care Institute 
 
  
Board Secretary: Shirley Sharp, Executive PA, Digital Health & 
Care Institute 
 
  
 
 
 
 
 
 
 ACTION 
BY 
1. &KDLU¶V,QWURGXFWLRQDQG$SRORJLHV 
7KH &KDLU ZHOFRPHG HYHU\RQH WR WRGD\¶V PHHWLQJ DQG WKDQNHG WKH
University of Strathclyde for hosting. The Chair also submitted apologies 
on behalf of those unable to attend. 
 
 
   
2. Declarations of Interest 
No declarations of interest were made. 
 
 
 
3. Minutes of last Meeting and Matters Arising 
The minutes of the last meeting of 16th November 2016, were agreed as 
an accurate record. 
 
Matters Arising 
x The chair advised that the CEO recruitment process is now fully 
underway and head hunters have been employed as an addition to 
assist the University recruitment process. 
x DC advised that all staff, including the team in Forres, have been 
briefed fully and the general mood going forward into phase two is 
very positive. The business case has also been submitted to the 
Scottish Funding Council, this will be discussed further during 
WRGD\¶VPHHWLQJ 
 
 
 
 
4. &KDLUPDQ¶V8SGDWH 
7KH&KDLUUDLVHGWKHLVVXHRIUHYLHZLQJ'+,¶VJRYHUQDQFHSURFHVVHVDQG
has agreed on a more simplified version being produced going forward. 
Templates have been received from a few of the other Innovation Centres 
to help assist with the review process. The Chair advised that it is hoped a 
draft document will be available to present to members at the next Board 
meeting in May. The Chair will arrange a meeting beforehand to discuss 
content with colleagues prior to the next Board meeting in May. 
 
The Chair advised that the CEO recruitment process is now fully underway 
and head hunters have been employed to assist with the University 
recruitment process. DC advised that down selection of candidates will 
take place on 3rd March, with interviews scheduled to take place on 24th 
March. DC has assisted UoS HR department on potential down selection 
and interview panel members. DL advised that he has had several 
conversations with interested parties, some of those internationally based, 
and is confident that there will be several good candidates for selection.  
 
HH introduced Louise McKean to Board members and advised colleagues 
that LMcK will take on several operational issues upon his departure; the 
next phase of DHI going forward will be one of them, and she will attend 
future Board meetings representing UoS and DHI interests.  
 
HH advised that regarding the CEO recruitment process, he will issue a 
note to Board members re timeline and input regarding the shortlisting and 
 
 
 
 
 
GC/UoS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HH/LMcK 
 
interview processes. HH advised that input will be sought from NHS, UoS 
and GSA colleagues. HH also advised that the University will also be 
seeking candidates for the position of Chairman when the current Chair 
steps down. CS asked for clarification on who will make the decision re 
&KDLUPDQ¶VSRVW++DGYLVHGWKDWDVWKLVLVQRWDSXEOLFDSSRLQWPHQWWKLV
should make the process more straight forward and timeous, but the Board 
will ultimately make the decision informed by UoS recommendations. HH 
advised that it is hoped that the appointment of the new Chairman will 
move in parallel with the CEO post if at all practicable. Expressions of 
interest will be sought and advertised on the University website next week. 
HH advised this will be an open and transparent process, able to stand up 
to SFC and public scrutiny. 
 
+5 HQTXLUHG DERXW 8QLYHUVLW\ RI (GLQEXUJK¶V UROH RQ '+, %RDUG *&
clarified that they are indeed part of the Board, represented by Professor 
Andrew Morris, and he has been sent invitations to all meetings to date. 
Unfortunately, he has been unable to attend any. It was therefore agreed 
by Board colleagues that if AM could not attend the meeting, then a depute 
should attend in his place. The Chair will seek clarification on 
representation from UoE going forward. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GC 
5. Update of Board Paper by CEO ± Paper presentation 
DC advised that the DHI business case had been submitted to SFC, with 
an offer of grant accepted by UoS to the value of £3m over two years. An 
additional £0.5m has been pledged by NHS Scotland in year one on 
condition of delivery, and Scottish Enterprise are also offering up to £1.3m 
subject to grant approval. 
 
Donna Chisholm, HIE arrived at 10.45am.  
 
DC advised that on looking forward to phase two, recruitment within 
engagement will be required fairly urgently. Discussions have taken place 
with colleague in HI&E and they have agreed to partly fund this role, with 
the post holder based in Inverness. DC advised that the establishment of 
advisory groups is also underway with UoS and GSA colleagues. Full 
teams have been briefed and from the 20th February, monthly 
management team meetings will take place in either Perth or Glasgow. A 
further whole team meeting will take place on the 20th March in Perth, to 
allow colleagues the opportunity to work more closely together. It is hoped 
this will happen on a regular basis going forward over the coming months, 
to try and establish closer working relationships within the broader team.  
 
DC advised it will be necessary to look at DHI branding and 
FRPPXQLFDWLRQVJRLQJ LQWRSKDVH WZR'+,¶VPLVVLRQKDVQRZFKDQJHG
significantly from phase one and this needs to be reflected in our internal 
and external communications. Phase one success and how it was 
measured has been a challenge and we need to look at how we do this 
better going forward. DC highlighted the three Challenge areas for Phase 
two and advised that over the next few weeks DHI hopes to receive further 
information from Scottish Government re specifics to the Challenges and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
JC 
 
 
confirmation of funding being committed. JC advised that it would be 
helpful to have a business development meeting beforehand to fine tune 
these areas, looking at deployment, spread and recognition for DHI.  
 
ColleaJXHVGLVFXVVHGWKHEURDGHUV\VWHPDQG'+,¶VUROHZLWKLQLWDQGKRZ
DOLJQPHQW WR 6FRWWLVK *RYHUQPHQW¶V 'LJLWDO +HDOWK IUDPHZRUN LV FUXFLDO
&ROOHDJXHVDJUHHGWKDW'+,¶VDFFRXQWDELOLW\QHHGVWREHGHILQHGWRKHOS
show impact. DL commented that he would hope for the next board 
meeting, DHI will be able to bring a document to the table, informed by the 
business development meeting, that will have specific details of what, how, 
who and funding required for phase 2 work agreed. This will then hopefully 
be adopted as a way forward into the next phase of DHI working.  
 
SD, Strategic Funding Director, DHI, joined the meeting at 11.20am.  
 
'&JDYHFROOHDJXHVDQXSGDWHRQ6)&¶V IXQGLQJSRVLWLRQPRYLQJ IURP
phase one into phase two. DC advised that after much discussion with 
SFC, DHI phase one will wind up on the 31st March. HR advised that SFC 
is supportive of this decision with discussion required to any remaining 
surplus of funds from phase one. HH advised that currently discussions 
are ongoing with Stuart Fancey, SFC, re retaining any surplus to roll into 
SKDVH%2¶&DVNHGIRUFODULILFDWLRQRQWKHQRWHDWWKHHQGRI)LQDO3KDVH
1 Projections of the Boardpack re estimated run rate. DC and MS advised 
that GSA figures had not been received by HA prior to calculations being 
made and that a reconciliation is required. The surplus cash figure will be 
clarified in due process. 
 
DC went on to discuss the DHI team moving from Eurocentral into 
Glasgow. Currently looking at two options within the Inovo building. Shared 
occupancy with IBIoIC on the 3rd floor or occupancy of available space on 
the 1st floor. Issue currently being that another tenant has first refusal on 
the space on the 3rd floor, but they have agreed to give a decision on this 
by the end of February, instead of the end of March. The 3rd floor will 
require to be fitted out, which would add additional cost and time to any 
potential move.  Should DHI be unable to co-locate with IBioIC on the, 3rd 
floor, the 1st floor becomes the preferred alternative, subject to cost 
analysis. The 1st floor office space is already furnished and available to 
move in now, which would allow for a move from Eurocentral almost as 
soon as would be deemed practicable. DC agreed to keep Board 
colleagues fully informed on this process.  
 
DC DGYLVHG WKDW6'KDVEHHQ LQYLWHG WR WRGD\¶V%RDUGPHHWLQJ WREULHI
FROOHDJXHVRQ'+,¶VFRPPHUFLDOSDUWQHUVKLSVZLWKODUJHFRUSRUDWLRQV6'
advised on significant projects and engagements involving DHI and others, 
e.g. Digital Pillcam Technology (NHS Highlands), Atrial Fribrillation - AF 
(NHS Lanarkshire as potential rollout), Outpatient Redesign and Home 
Vent. JC advised that he would like more information on the Pillcam project 
and its potential impact on roll out. SD advised that he would be happy to 
send JC information or arrange to meet regarding this. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DC 
 
 
 
 
 
 
 
 
SD 
 
 
 
 
JC 
 
SD also advised on a collaboration agreement between DHI, Macmillan 
Cancer Care and Abertay University re a personalised care plan for cancer 
care patients using gaming technology. Discussion ensued and JC agreed 
that regular business development meetings should be held with SG and 
DHI, and he will introduce colleagues with a view to helping create links to 
SG advisory boards re operational delivery. SD went on to discuss the 
need to create pathways with corporate to ensure early adoption, 
development and route to market. JC advised that he will endeavour to 
arrange a meeting with CLO at NSS to discuss practicalities around this. 
Board colleagues discussed the need for additional external funding for 
DHI going forward and the need to have DHI promoted at an international 
OHYHO %2¶& DGYLVHG WKDW (&+ $OOLDQFH ZRXOG EH KDSS\ WR DVVLVW DQG
advised on that there are alternative funding routes to be investigated 
within Europe.  
 
DCH also discussed an upcoming SBRI supported by Innovate UK re 
Inflammatory Bowel Disease, the third stage of which is due to start at the 
beginning of March, involving two health boards in the north and two in the 
central belt. Procurement will be involved at the outset with potential 
investment funds available of up to £0.5m. JC asked for Donna Chisholm 
to send further details on the SBRI as he would like to send a 
representative from NHS Scotland to attend. Both agreed to update 
colleagues at the next Board meeting in May. 
 
 
JC 
 
 
 
 
 
 
 
 
 
 
 
DCH/JC 
6. Update on Board Paper ± CEO 
'& DGYLVHG WKDW PRVW RI WRGD\¶V GLVFXVVLRQ KDV FRYHUHG WKH KLJKOLJKWV
GLVFXVVHGLQWRGD\¶V%RDUGSDSHU'&FRQILUPHGWKHclosing down of phase 
one and moving forward into phase two from the beginning of April. DC 
advised that clarification and staffing implications have been particularly 
challenging, and DC has advised that a formal written request is being 
submitted to SFC re any underspend as discussed previously. 
 
DC advised that relationships with DHI/UoS and GSA are moving forward 
and in a constructive positive manner. DC advised that UoS are keen not 
to have the same contract with GSA as in phase one, but to work on an 
almost sub-contract basis with a whole team approach and to ensure that 
it will be contractually binding for all parties. Louise McKean and her GSA 
counterparts are currently in the process of drafting this. MS advised that 
investment going forward has been challenging and that some GSA staff 
will be leaving at the end of phase one. Colleagues went on to discuss the 
need to focus on good business planning dealing with the challenges 
ahead. The need to take a broader approach to what is available in 
Scotland and to draw from the best contributors wherever DHI may need 
LW%2¶&KLJKOLJKWHGWKHQHHGIRUUREXVWFRUSRUDWHJRYHUQDQFHDQGIRUWKLV
to be articulated in writing to Board members, as this has not always been 
clear in the past, along with roles and responsibilities for its members.   
 
 
 
 
 
 
 
 
 
 
7. AOB 
IB advised that Innovate UK now have a Scottish Ambassador in Scotland. 
His name is Bob Martin and he is keen to form relationships with key 
stakeholders in Scotland. IB will send on his details to the Board. DCH also 
 
 
 
 
discussed the Industrial Strategy Challenge Fund. Potential monies may 
be available from this Innovate UK fund. DCH and IB will discuss offline. 
 
*&DGYLVHGFROOHDJXHVWKDWWKLVZRXOGEH++¶VODVW'+,%RDUGPHHWLQJDV
he will be leaving UoS to become Principal of Fife College at the end of the 
month. GC thanked HH on behalf of the DHI Board, for all his hard work 
and input towards trying to secure a future for DHI and its staff. GC and 
colleagues would like to wish HH well in his new role. 
 
IMcA asked for clarification on GSA bespoke funded masters with NHS. 
HR advised that it would be worth getting in touch with her colleague 
Sophie Lowrie at SFC re this. IMcA agreed to contact SL. 
 
-&DGYLVHG%RDUGFROOHDJXHVRQ6FRWWLVK*RYHUQPHQW¶VH+HDOWKVWUDWHJ\
It is hoped he will be able to table this DWWKHQH[WPHHWLQJLQ0D\%2¶&
offered the assistance of the ECH Alliance to help inform the new strategy. 
-& DJUHHG WR WKH FXUUHQW GUDIW WR %2¶& IRU(&+ $OOLDQFH YLHZV 6KLUOH\
6KDUSZLOOVHQGGHWDLOVWR-&DQG%2¶& 
DCH/IB 
 
 
 
 
 
 
 
 
 
 
IMcA 
 
 
 
JC 
SS 
 
8. Date and Time of Next meeting 
Date and time of next meeting to be arranged. 
 
 
 
 
 
 
 
